|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PARRIS N. GLENDENING, Governor
|
|
Ch. 17
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) THE AMOUNT OF MONEY THAT WAS ALLOCATED TO EACH
COMPONENT OF THE PROGRAM DURING:
(I) THE PRIOR FISCAL YEAR THAT REMAINED UNSPENT AND
UNOBLIGATED AT THE END OF THAT YEAR; AND
(II) THE CURRENT FISCAL YEAR THAT REMAINED UNSPENT AND
UNOBLIGATED AS OF DECEMBER 31 OF THE PRECEDING CALENDAR YEAR; AND
(2) THE AMOUNT OF MONEY THAT WAS DISTRIBUTED AS GRANTS TO
EACH RECIPIENT IN THE PRIMARY HEALTH CARE COMPONENT, THE CANCER
PREVENTION, IDENTIFICATION, AND TREATMENT MAJOR COMMUNITY HOSPITAL
COMPONENT, THE TOBACCO RELATED DISEASES COMPONENT, THE CANCER AND
TOBACCO RELATED DISEASES PRIMARY HEALTH CARE PROGRAM IN THE PRIMARY
HEALTH CARE LOCAL PUBLIC HEALTH COMPONENT, THE TARGETED HOSPITAL
CAPACITY COMPONENT, AND THE STATEWIDE ACADEMIC HEALTH CENTER
COMPONENT:
(I) THE PRIOR FISCAL YEAR THAT REMAINED UNSPENT AND
UNOBLIGATED AT THE END OF THAT YEAR; AND
(II) THE CURRENT FISCAL YEAR THAT REMAINED UNSPENT AND
UNOBLIGATED AS OF DECEMBER 31 OF THE PRECEDING CALENDAR YEAR
13-1103.
(A) THERE IS A SURVEILLANCE AND EVALUATION COMPONENT IN THE
PROGRAM.
(1) THE PURPOSE OF THE SURVEILLANCE AND EVALUATION COMPONENT IS TO:
(1) COLLECT, ANALYZE, AND MONITOR DATA RELATING TO CANCER AND
CANCER PREVENTION, IDENTIFICATION, AND TREATMENT IN THE STATE;
(2) MEASURE AND EVALUATE THE RESULTS OF THE PROGRAM,
INCLUDING THE RESULTS OF EACH COMPONENT OF THE PROGRAM;
(3) CONDUCT THE BASELINE CANCER STUDY, AS PROVIDED UNDER
SUBSECTIONS (C) AND (D) OF THIS SECTION; AND
(4) CONDUCT AN ANNUAL CANCER STUDY, AS PROVIDED UNDER §
13-1104 OF THIS SUBTITLE.
(C) (1) TO INITIATE THE SURVEILLANCE AND EVALUATION COMPONENT,
THE DEPARTMENT SHALL CONDUCT A COMPREHENSIVE STATEWIDE BASELINE
CANCER STUDY AS PROVIDED IN THIS SECTION.
(2) THE DEPARTMENT MAY;
(I) CONDUCT THE BASELINE CANCER STUDY OR ANY PART OF THE
STUDY; OR
|
|
|
|
|
|
|
|
|
|
- 211 -
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
